Bio-Rad acquires single-cell analysis company

By The Science Advisory Board staff writers

April 9, 2020 -- Bio-Rad Laboratories has acquired Celsee, a company that offers instruments and consumables for single-cell analysis.

Celsee's Genesis system helps scientists isolate, interpret, and analyze the behavior of single cells. The technology is designed for single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment and enumeration, and immune monitoring.

Bio-Rad did not disclose terms of the acquisition, but it will provide further updates regarding Celsee during its first-quarter 2020 financial results call.

Shortage of RNA extraction kits threatens coronavirus testing
The weak link in the U.S. response to diagnostic testing for the novel coronavirus SARS-CoV-2 could be a shortage of RNA extraction kits. Fortunately,...
CRISPR - A New Era in Genome Editing
A major buzzword in the science world recently has been CRISPR: short for Clustered Regularly Interspaced Short Palindromic Repeats. This is a simple,...
Competition within Single-Cell Analysis Technology
The excitement surrounding the ability to measure genomic, epigenomic, transcriptomic, and metabolic status in individual cells is reflected in the high...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter